Brexit and the Healthcare Industry – Implications for Pharma, Q1 2018

brexit-and-the-eu

It has been almost two years since the UK voted to leave the EU. Businesses were told a vote to leave the EU would drive the UK into a severe recession, yet markets are up. Negotiations are ongoing to determine the UK’s post-Brexit relationship with the EU.

This report provides an assessment of how the pharmaceutical industry expects Brexit to affect the healthcare sector, both within and outside of Britain. This study will be repeated at the end of Q2 this year, to gauge the changing sentiment towards Brexit from within the healthcare industry.

This report provides in-house analyst expertise on the results of a 10 minutes survey of 155 GlobalData Pharma clients and prospects which was fielded from April 9, 2018 to April 23, 2018. Participants answered questions about how they expected Brexit to affect the healthcare sector, both within and outside of the UK. Components of the slide deck include –

  • Factors to Impact Healthcare: key factors to impact the post-Brexit UK healthcare industry providing respondent mix by region and seniority level
  • Impact on Research and Manufacturing: key factors to impact healthcare research and manufacturing in the UK post-Brexit providing respondent mix by region and seniority level
  • Impact on Corporate Strategy: level of impact of Brexit on corporate strategy providing respondent mix by region, seniority level, and headquarter location
  • Impact on Relocation: impact of Brexit on staff and headquarter relocation as indicated by resondents whose headquarters is located in the UK

Reasons to buy

  • Develop and design your corporate strategies post-Brexit through an in-house expert analysis of the key factors to impact the post-Brexit UK healthcare industry.
  • Develop business strategies by understanding the key factors to impact healthcare research and manufacturing in the UK post-Brexit.
  • Stay up to date on the industry’s changing sentiment towards Brexit from within the healthcare industry with quarterly surveys.
  • Identify emerging industry trends post-Brexit to gain a competitive advantage.

 

Brexit and the Healthcare Industry – Implications for Pharma, Q1 2018

Report Information:
Single User License Price:
 $500
Published: 2018
Publisher: GlobalData
Report Format: electronic pdf

Advertisements

Healthcare Construction Projects, Asia Pacific

Construction caption

GlobalData’s Construction Intelligence Center is currently tracking healthcare construction projects in Asia-Pacific with a total value of US$116.3 billion, which includes projects from the announced to execution stages.

Need for an increase in investment in new healthcare facilities in the region is paramount, given the expected increase in old-age populations across the region. According to the OECD the share of the population aged 65 years and over in Asian countries is expected to increase from 8.1% in 2015 to reach 20.5% in 2050. Life expectancy at birth across 22 Asian countries reached 73.7 years in 2015, a larger gain than in OECD countries.

China, being the most populous country and the economic power for the region, has the highest value healthcare construction project pipeline, totaling US$48.6 billion. However, China is at the lower end of the measure of healthcare expenditure relative to GDP, at around 5.5% of GDP compared to the US with close to 17% and Australia’s 9.4%. It is a similar situation in India, which has a project pipeline valued at US$15.9 billion, but spends less than 4% of its GDP on healthcare.

 

Healthcare Construction Projects, Asia Pacific

Report Information:
Single User License Price:
 $1950
Published: 2018
Publisher: GlobalData
Report Format: electronic pdf

Home & Garden Products Global Industry Guide 2018-2022

Home_Garden

Global Home & Garden Products industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

 

Key highlights –

The global home and garden products market had total revenues of $1,448.7bn in 2017, representing a compound annual growth rate (CAGR) of 5.4% between 2013 and 2017.

The home improvement segment was the market’s most lucrative in 2017, with total revenues of $771.8bn, equivalent to 53.3% of the market’s overall value.

As the largest market, which made up 39.2% of the global total value in 2017, the US remains a nation of homebuyers. Although the rate of home ownership still lies behind the 2005 high of 69%, 2017 saw the rate climb back up to 63.9% by the end of Q3.

Key Questions Answered:

• What was the size of the global home & garden products market by value in 2017?
• What will be the size of the global home & garden products market in 2022?
• What factors are affecting the strength of competition in the global home & garden products market?
• How has the market performed over the last five years?
• What are the main segments that make up the global home & garden products market?

 

Home & Garden Products Global Industry Guide 2018-2022

Report Information:
Single User License Price:
 $1495
Published: 2018
Report Format: electronic pdf